Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2012 1
2013 2
2014 1
2015 3
2016 1
2017 3
2018 2
2019 4
2020 4
2021 8
2022 3
2023 4
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

33 results

Results by year

Filters applied: . Clear all
Page 1
Evaluating the Alzheimer's disease data landscape.
Birkenbihl C, Salimi Y, Domingo-Fernándéz D, Lovestone S; AddNeuroMed consortium; Fröhlich H, Hofmann-Apitius M; Japanese Alzheimer's Disease Neuroimaging Initiative; and the Alzheimer's Disease Neuroimaging Initiative. Birkenbihl C, et al. Alzheimers Dement (N Y). 2020 Dec 16;6(1):e12102. doi: 10.1002/trc2.12102. eCollection 2020. Alzheimers Dement (N Y). 2020. PMID: 33344750 Free PMC article.
Etiology of White Matter Hyperintensities in Autosomal Dominant and Sporadic Alzheimer Disease.
Shirzadi Z, Schultz SA, Yau WW, Joseph-Mathurin N, Fitzpatrick CD, Levin R, Kantarci K, Preboske GM, Jack CR Jr, Farlow MR, Hassenstab J, Jucker M, Morris JC, Xiong C, Karch CM, Levey AI, Gordon BA, Schofield PR, Salloway SP, Perrin RJ, McDade E, Levin J, Cruchaga C, Allegri RF, Fox NC, Goate A, Day GS, Koeppe R, Chui HC, Berman S, Mori H, Sanchez-Valle R, Lee JH, Rosa-Neto P, Ruthirakuhan M, Wu CY, Swardfager W, Benzinger TLS, Sohrabi HR, Martins RN, Bateman RJ, Johnson KA, Sperling RA, Greenberg SM, Schultz AP, Chhatwal JP; Dominantly Inherited Alzheimer Network and the Alzheimer’s Disease Neuroimaging Initiative. Shirzadi Z, et al. JAMA Neurol. 2023 Dec 1;80(12):1353-1363. doi: 10.1001/jamaneurol.2023.3618. JAMA Neurol. 2023. PMID: 37843849
Immunity gene IFITM3 variant: Relation to cognition and Alzheimer's disease pathology.
Pyun JM, Park YH, Hodges A, Jang JW, Bice PJ, Kim S, Saykin AJ, Nho K; AddNeuroMed Consortium and the Alzheimer's Disease Neuroimaging Initiative. Pyun JM, et al. Alzheimers Dement (Amst). 2022 Jun 21;14(1):e12317. doi: 10.1002/dad2.12317. eCollection 2022. Alzheimers Dement (Amst). 2022. PMID: 35769874 Free PMC article.
Cognitive Trajectories in Preclinical and Prodromal Alzheimer's Disease Related to Amyloid Status and Brain Atrophy: A Bayesian Approach.
Teipel SJ, Dyrba M, Levin F, Altenstein S, Berger M, Beyle A, Brosseron F, Buerger K, Burow L, Dobisch L, Ewers M, Fliessbach K, Frommann I, Glanz W, Goerss D, Gref D, Hansen N, Heneka MT, Incesoy EI, Janowitz D, Keles D, Kilimann I, Laske C, Lohse A, Munk MH, Perneczky R, Peters O, Preis L, Priller J, Rostamzadeh A, Roy N, Schmid M, Schneider A, Spottke A, Spruth EJ, Wiltfang J, Düzel E, Jessen F, Kleineidam L, Wagner M; DELCODE study group and the Alzheimer’s Disease Neuroimaging Initiative. Teipel SJ, et al. J Alzheimers Dis Rep. 2023 Sep 26;7(1):1055-1076. doi: 10.3233/ADR-230027. eCollection 2023. J Alzheimers Dis Rep. 2023. PMID: 37849637 Free PMC article.
Evaluating the Effect of Alzheimer's Disease-Related Biomarker Change in Corticobasal Syndrome and Progressive Supranuclear Palsy.
Garcia-Cordero I, Anastassiadis C, Khoja A, Morales-Rivero A, Thapa S, Vasilevskaya A, Davenport C, Sumra V, Couto B, Multani N, Taghdiri F, Anor C, Misquitta K, Vandevrede L, Heuer H, Tang-Wai D, Dickerson B, Pantelyat A, Litvan I, Boeve B, Rojas JC, Ljubenkov P, Huey E, Fox S, Kovacs GG, Boxer A, Lang A, Tartaglia MC; 4‐R‐Tauopathy Neuroimaging Initiative Consortium, and the Alzheimer's Disease Neuroimaging Initiative. Garcia-Cordero I, et al. Ann Neurol. 2024 Apr 5. doi: 10.1002/ana.26930. Online ahead of print. Ann Neurol. 2024. PMID: 38578117
Circulating ethanolamine plasmalogen indices in Alzheimer's disease: Relation to diagnosis, cognition, and CSF tau.
Kling MA, Goodenowe DB, Senanayake V, MahmoudianDehkordi S, Arnold M, Massaro TJ, Baillie R, Han X, Leung YY, Saykin AJ, Nho K, Kueider-Paisley A, Tenenbaum JD, Wang LS, Shaw LM, Trojanowski JQ, Kaddurah-Daouk RF; Alzheimer's Disease Metabolomics Consortium (ADMC) and the Alzheimer's Disease Neuroimaging Initiative (ADNI). Kling MA, et al. Alzheimers Dement. 2020 Sep;16(9):1234-1247. doi: 10.1002/alz.12110. Epub 2020 Jul 27. Alzheimers Dement. 2020. PMID: 32715599 Free PMC article.
Resting-State Network Alterations Differ between Alzheimer's Disease Atrophy Subtypes.
Rauchmann BS, Ersoezlue E, Stoecklein S, Keeser D, Brosseron F, Buerger K, Dechent P, Dobisch L, Ertl-Wagner B, Fliessbach K, Haynes JD, Heneka MT, Incesoy EI, Janowitz D, Kilimann I, Laske C, Metzger CD, Munk MH, Peters O, Priller J, Ramirez A, Roeske S, Roy N, Scheffler K, Schneider A, Spottke A, Spruth EJ, Teipel S, Tscheuschler M, Vukovich R, Wagner M, Wiltfang J, Yakupov R, Duezel E, Jessen F, Perneczky R; DELCODE study group and the Alzheimer's Disease Neuroimaging Initiative (ADNI). Rauchmann BS, et al. Cereb Cortex. 2021 Oct 1;31(11):4901-4915. doi: 10.1093/cercor/bhab130. Cereb Cortex. 2021. PMID: 34080613 Free PMC article.
Examining the association between genetic liability for schizophrenia and psychotic symptoms in Alzheimer's disease.
Creese B, Vassos E, Bergh S, Athanasiu L, Johar I, Rongve A, Medbøen IT, Vasconcelos Da Silva M, Aakhus E, Andersen F, Bettella F, Braekhus A, Djurovic S, Paroni G, Proitsi P, Saltvedt I, Seripa D, Stordal E, Fladby T, Aarsland D, Andreassen OA, Ballard C, Selbaek G; AddNeuroMed consortium and the Alzheimer’s Disease Neuroimaging Initiative. Creese B, et al. Transl Psychiatry. 2019 Oct 22;9(1):273. doi: 10.1038/s41398-019-0592-5. Transl Psychiatry. 2019. PMID: 31641104 Free PMC article.
33 results